AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-137076522/ambien-cr-approved-newest.html" title="Facts and information about Ambien CR is approved as newest sleeping aid.(developed by Sanofi-Aventis S.A.)(Brief Article)">Ambien CR is approved as newest sleeping aid.(developed by Sanofi-Aventis S.A.)(Brief Article)</a>
Close
Set up an RSS feed that alerts you when new articles from Chain Drug Review are available.
Frequently asked questions about RSS feeds
Ambien CR is approved as newest sleeping aid.(developed by Sanofi-Aventis S.A.)(Brief Article)
Sanofi-Aventis has won Food and Drug Administration approval for Ambien CR, a new version of its sleeping pill. The product is the first extended-release medication indicated for sleep induction and maintenance. Ambien CR is available in a 12.5-mg ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- AMBIEN CR(TM) (Zolpidem Tartrate Extended-Release Tablets) CIV Receives FDA...
- Press release article from: PR Newswire September 6, 2005 700+ words
...therapy worldwide, since the first launch. AMBIEN CR will be available in a 12.5 mg dose recommended for adults and a 6.25 mg dose recommended for the elderly. About AMBIEN CR AMBIEN CR is indicated for the treatment of insomnia...
- AMBIEN CR(TM) Now Available in the U.S. for the Treatment of Insomnia.
- Press release article from: PR Newswire October 7, 2005 700+ words
...worldwide, since the first launch. AMBIEN CR(TM) is now available in a 12.5 mg dose recommended for adults and a 6.25...recommended for the elderly. About AMBIEN CR AMBIEN CR is indicated for the treatment...
- Ambien CR(R) (zolpidem tartrate extended-release) tablets CIV Improved Chronic...
- Press release article from: PR Newswire January 4, 2008 700+ words
...results from a new study that showed Ambien CR(R) (zolpidem tartrate extended...disorder (GAD) compared to placebo. Ambien CR also improved sleep-related next...total sleep time in patients treated with Ambien CR and the antidepressant escitalopram...
- Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia...
- Press release article from: PR Newswire June 10, 2008 700+ words
Ambien CR(R) 12.5 mg significantly improved...results from a new study that showed Ambien CR(R) (zolpidem tartrate extended...Reuptake Inhibitor (SSRI) for depression. Ambien CR also improved sleep-related next...
- New Data Show Improvements in Work Performance in Patients with Chronic...
- Press release article from: PR Newswire October 24, 2007 700+ words
Study Confirms Role of AMBIEN CR in Effectively Managing Insomnia to...who were treated with 12.5 mg of AMBIEN CR(R) (zolpidem tartrate extended...evaluated the efficacy and safety of AMBIEN CR when taken as needed, were recently...
- Ambien CR raises sleep time in insomnia with GAD.
- Newspaper article from: Pharma Marketletter January 14, 2008 700+ words
...Aventis says that new study data showed Ambien CR (zolpidem tartrate extended-release...Total sleep time was increased in the Ambien CR group throughout the study. At week...0.0001). On average, those on Ambien CR fell asleep sooner and exhibited improved...
- Barr Confirms Patent Challenge of Ambien CR(R).
- Press release article from: PR Newswire April 6, 2007 700+ words
...for Sanofi-Aventis U.S. LLC's Ambien CR(R) (Zolpidem Tartrate Extended...paragraph IV certification for a generic Ambien CR product with the U.S. Food &...process under the Hatch-Waxman Act. Ambien CR (Zolpidem Tartrate Extended-Release...
- FDA issues approvable letter for AMBIEN CR CIV for the treatment of...
- Magazine article from: Pharmaceutical Processing May 1, 2005 700+ words
...an approvable letter from the FDA for AMBIEN CR (zolpidem tartrate extended release) CIV. AMBIEN CR[TM] is the controlled-release formulation...FDA's questions relate specifically to AMBIEN CR[TM] and are not related to the safety...
